Global /South Korea /Healthcare /Medical Distribution /019660

Globon Co., Ltd.

019660

• KRX: 019660 • Delayed

2,225KRW -1.1%

1.45 USD

As of 6 June 2026, Globon Co., Ltd. has a market cap of $20.24M USD, ranking #37004 globally and #2353 in South Korea. It ranks #3319 in the Healthcare sector, and #150 in the Medical Distribution industry.

Global Rank

37004

Country Rank

2353

Sector Rank

3319

Industry Rank

150

Key Stats

Market Cap

$20.24MUSD

31.03B KRW

Revenue (TTM)

$3.38MUSD

5.18B KRW

EBITDA (TTM)

-$3.86MUSD

-5.92B KRW

Net Income (TTM)

-$8.01MUSD

-12.27B KRW

EBITDA Margin

-114%

Profit Margin

-237%

PS Ratio

6.0

PB Ratio

1.7

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Distribution

CEO

Sang-Ho Han open_in_new

Founded

1986

Website

globon.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.1%	-4.1%	-0.9%	-13%	-21%	-14%	-26%	-66%	-83%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	019660 글로본(주) ISIN: KR7019660000 Shares Out.: Shares Outstanding: 13.943M¹ Shares Float: 11.988M² TV: TradingView: KRX: 019660 SA: Stock Analysis: KRX: 019660 YF: Yahoo Finance: 019660.KS GF: Google Finance: KRX: 019660 BA: Barron's: 019660 MS: Morningstar: XKRX: 019660	2,225 KRW	TV: TradingView: KRX: 019660 SA: Stock Analysis: KRX: 019660 YF: Yahoo Finance: 019660.KS GF: Google Finance: KRX: 019660 BA: Barron's: 019660 MS: Morningstar: XKRX: 019660

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Globon Co., Ltd.

Globon Co., Ltd. engages in wholesale and retail of cosmetics. It is also involved in manufacturing of cosmetic containers; and selling household goods. In addition, the company engages in the hydrogen purification equipment and investment businesses. The company was formerly known as Veritas Investment Co., Ltd. and changed its name to Globon Co., Ltd. in December 2015. Globon Co., Ltd. was founded in 1986 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Medical Distribution (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Hanmi Science Co., Ltd. KRX: 008930	$1.68B 2.57T KRW 8K%	21.8	South Korea
HLB Life Science Co., Ltd. KRX: 067630	$341.42M 523.33B KRW 2K%	-	South Korea
HLB Therapeutics Co.,Ltd. KRX: 115450	$213.17M 326.75B KRW 953%	-	South Korea
Manyo Factory Co., Ltd. KRX: 439090	$179.57M 275.24B KRW 787%	30.1	South Korea
Ensol Biosciences, Inc. KRX: 140610	$102.3M 156.81B KRW 405%	-	South Korea
Aminologics Co.,Ltd. KRX: 074430	$82.74M 126.82B KRW 309%	36.1	South Korea

Industry: Medical Distribution (Global)

Name	Market Cap (USD) diff.	PE	Country
McKesson Corp. NYSE: MCK	$100.76B 498K%	24.0	United States
Cencora, Inc. NYSE: COR	$60.58B 299K%	37.4	United States
Cardinal Health, Inc. NYSE: CAH	$47.73B 236K%	29.6	United States
Henry Schein, Inc. NASDAQ: HSIC	$8.47B 42K%	22.6	United States
Sinopharm Group Co. Ltd. SHEK: 1099	$7.48B 58.61B HKD 37K%	7.2	China
Galenica AG SIX: GALE	$5.32B 4.2B CHF 26K%	23.0	Switzerland

chevron_leftBack